Methods for testing and producing (-) strand rna virus vectors with reduced particle formation ability
CA 2460778 A1 · Owner: Inoue, Makoto · Inventors: Inoue, Makoto; Iida, Akihiro; Tokusumi, Yumiko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide a method of examining a (-) strand RNA virus vector having a lowered ability to form grains or a lowered cytotoxicity or lacking the same; and a method of constructing producing the vector. It is found out that the formation of virus-like grains in cells having a (-) strand RNA virus vector transferred thereinto can be regulated by lowering or eliminating the localization of M protein expressed in the cells. Thus a method of examining , a (-) strand RNA virus vector having a lowered ability to form grains or lacking the ability, a screening method and a method of constructing the (-) , strand RNA virus vector having a lowered ability to form grains or lacking …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 18, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 18, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 18, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.